Role of brain nitric oxide in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats

Brain Research

Volumn 795, Issue 1-2, 1998, Pages 257-263

  Zheng, Yiwen ^a   Laverty, Richard ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

( )3,4 methylenedioxymethamphetamine; N( ) nitro L arginine; Neuroprotection; Nitric oxide; Nitric oxide synthase

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FRONTAL CORTEX; HYPERTHERMIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARIETAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BODY TEMPERATURE; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDROXYINDOLEACETIC ACID; INDAZOLES; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 0032496695     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00313-8     Document Type: Article

References (40)

1. J.F. Bowyer, D.L. Davies, L. Schmued, H.W. Broening, G.D. Newport, W. Slikker, R.R. Holson, Further studies of the role of hyperthermia in methamphetamine neurotoxicity, J. Pharmacol. Exp. Ther. 268 (1994) 1571-1580.
2. D.S. Bredt, P.M. Hwang, S.H. Snyder, Localization of nitric oxide synthase indicating a neural role for nitric oxide, Nature 347 (1990) 768-770.
3. D.S. Bredt, S.H. Snyder, Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 682-685.
4. C. Cerruti, P. Sheng, B. Ladenheim, C.J. Epstein, J.-L. Cadet, Involvement of oxidative and L-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro, Clin. Exp. Pharmacol. Physiol. 22 (1995) 381-382.
5. M.I. Colado, T.K. Murray, A.R. Green, 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine, Br. J. Pharmacol. 108 (1993) 583-589.
6. M.I. Colado, J.L. Williams, A.R. Green, The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the dark agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype, Br. J. Pharmacol. 115 (1995) 1281-1289.
7. D.L. Commins, G. Vosmer, R.M. Virus, W.L. Woolverton, C.R. Schuster, L.S. Seiden, Biochemical and histological evidence that methylenedioxymethylamphetamine(MDMA) is toxic to neurons in the rat brain, J. Pharmacol. Exp. Ther. 241 (1987) 338-345.
8. V.L. Dawson, T.M. Dawson, D.A. Bartley, G.R. Uhl, S.H. Snyder, Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures, J. Neurosci. 13 (1993) 2651-2661.
9. V.L. Dawson, V.M. Kizushi, P.L. Huang, S.H. Snyder, T.M. Dawson, Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice, J. Neurosci. 16 (1996) 2479-2487.
10. D.A. Di Monte, J.E. Royland, M.W. Jakowec, J.W. Langston, Role of nitric oxide in methamphetamine neurotoxicity: protection by nitric oxide synthase, J. Neurochem. 67 (1996) 2443-2450.
11. G.M. Farfel, L.S. Seiden, Role of hypothermia in the mechanism of protection against serotonergic toxicity: II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan, J. Pharmacol. Exp. Ther. 272 (1995) 868-875.
12. G.M. Farfel, G.L. Vosmer, L.S. Seiden, The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine, Brain Res. 595 (1992) 121-127.
13. U. Förstermann, L.D. Gorsky, J.S. Pollock, H.H.H.W. Schmidt, M. Heller, F. Murad, Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain, Biochem. Biophys. Res. Commun. 168 (1990) 727-732.
14. P.G. Gunasekar, A.G. Kanthasamy, J.L. Borowitz, G.E. Isom, NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death, J. Neurochem. 65 (1995) 2016-2021.
15. K.E. Hewitt, A.R. Green, Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('ecstasy') to rats, Neuropharmacology 33 (1994) 1589-1595.
16. Y. Itzhak, S.F. Ali, The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo, J. Neurochem. 67 (1996) 1770-1773.
17. M.S. Kleven, W.L. Woolverton, L.S. Seiden, Evidence that both intragastric and subcutaneous administration of methylenedioxymethamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys, Brain Res. 488 (1989) 121-125.
18. 3H]dopamine release from striatal slices, J. Neurosci. Res. 35 (1993) 192-198.
19. R. Laverty, B.J. Logan, Protection by MK 801 and other drugs of methylenedioxy-methamphetamine (MDMA) neurotoxicity in rats and mice, Eur. J. Pharmacol. 183 (1990) 451-452.
20. B.J. Logan, R. Laverty, W.D. Sanderson, Y.B. Yee, Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity, Eur. J. Pharmacol. 152 (1988) 227-234.
21. D. Luo, S.R. Vincent, NMDA-dependent nitric oxide release in the hippocampus in vivo: interactions with noradrenaline, Neuropharmacology 33 (1994) 1345-1350.
22. D.B. Miller, J.P. O'Callaghan, Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Ther. 270 (1994) 752-760.
23. S. Moncada, R.M.J. Palmer, E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109-142.
24. J.F. Nash, Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis, Life Sci. 47 (1990) 2401-2408.
25. J.F. Nash, B.K. Yamamoto, Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine, Brain Res. 581 (1992) 237-243.
26. J.P. O'Callaghan, D.B. Miller, Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse, J. Pharmacol. Exp. Thur. 270 (1994) 741-751.
27. T. Ohmori, T. Abekawa, T. Koyama, The role of glutamate in behavioral and neurotoxic effects of methamphetamine, Neurochem. Int. 29 (1996) 301-307.
28. P.S. Puttfarcken, W.E. Lyons, J.T. Coyle, Dissociation of nitric oxide generation and kainate-mediated neuronal degeneration in primary cultures of rat cerebellar granule cells, Neuropharmacology 31 (1992) 565-575.
29. G. Ricaurte, G. Bryan, L. Strauss, L. Seiden, C. Schuster, Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals, Science 229 (1985) 986-988.
30. G.A. Ricaurte, L.S. Forno, M.A. Wilson, L.E. DeLanney, I. Irwin, M.E. Molliver, J.W. Langston, (±)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates, JAMA 260 (1988) 51-55.
31. C.J. Schmidt, Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine, J. Pharmacol. Exp. Ther. 240 (1987) 1-7.
32. C.J. Schmidt, C.K. Black, V.L. Taylor, Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine, Eur. J. Pharmacol. 181 (1990) 59-70.
33. C.J. Schmidt, J.H. Kehne, Neurotoxicity of MDMA: neurochemical effects, Ann. N.Y. Acad. Sci. 600 (1990) 665-680.
34. C.J. Schmidt, J.A. Levin, W. Lovenberg, In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain, Biochem. Pharmacol. 36 (1987) 747-755.
35. J.E. Sprague, X. Huang, A. Kanthasamy, D.E. Nichols, Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan, Life Sci. 55 (1994) 1193-1198.
36. D.M. Stone, K.M. Merchant, G.R. Hanson, J.W. Gibb, Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat, Neuropharmacology 26 (1987) 1677-1683.
37. ω-nitro-L-arginine in rats, Br. J. Pharmacol. 111 (1994) 394-396.
38. S.R. Vincent, Nitric oxide: a radical neurotransmitter in the central nervous system, Prog. Neurobiol. 42 (1994) 129-160.
39. Y. Zheng, B. Russell, D. Schmierer, R. Laverty, The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice, J. Pharm. Pharmacol. 49 (1997) 89-96.
40. X.-Z. Zhu, L.-G. Luo, Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices, J. Neurochem. 59 (1992) 932-935.